RI
TXG icon

RTW Investments’s 10x Genomics TXG Stock Holding History

RTW Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-502,856
Closed -$11.4M – 76
2024
Q3 		$11.4M Hold
502,856
– – 0.16% 52
2024
Q2 		$9.78M Sell
502,856
-1,052,000
-68% -$27.5M 0.15% 50
2024
Q1 		$58.4M Buy
1,554,856
+4,905
+0.3% +$216K 0.86% 35
2023
Q4 		$86.7M Buy
1,549,951
+29,995
+2% +$1.31M 1.35% 24
2023
Q3 		$62.7M Buy
1,519,956
+57,000
+4% +$2.97M 1.32% 22
2023
Q2 		$81.7M Buy
1,462,956
+533,670
+57% +$28.9M 1.56% 22
2023
Q1 		$51.8M Buy
929,286
+56,694
+6% +$2.65M 1.08% 25
2022
Q4 		$31.8M Buy
872,592
+232,938
+36% +$7.62M 0.65% 34
2022
Q3 		$18.2M Sell
639,654
-319,827
-33% -$12.2M 0.42% 41
2022
Q2 		$43.4M Buy
959,481
+225,000
+31% +$11.7M 1.12% 30
2022
Q1 		$55.9M Hold
734,481
– – 1.16% 32
2021
Q4 		$109M Hold
734,481
– – 1.6% 23
2021
Q3 		$107M Hold
734,481
– – 1.61% 22
2021
Q2 		$144M Buy
734,481
+22,966
+3% +$4.16M 2.17% 13
2021
Q1 		$129M Buy
711,515
+50,582
+8% +$8.73M 2.01% 14
2020
Q4 		$93.6M Hold
660,933
– – 1.57% 20
2020
Q3 		$82.4M Buy
660,933
+24,841
+4% +$2.61M 1.98% 16
2020
Q2 		$56.8M Buy
636,092
+445,983
+235% +$34.7M 1.6% 23
2020
Q1 		$11.8M Buy
190,109
+185,109
+3,702% +$14.4M 0.51% 40
2019
Q4 		$381K Hold
5,000
– – 0.01% 60
2019
Q3 		$252K Buy
+5,000
New +$277K 0.02% 60

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RTW Investments's TXG Position: Q4 2024 in Review

RTW Investments sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 502,856 shares — an estimated $11.4M sold.

RTW Investments first reported a position in TXG in Q3 2019 and held it in 21 quarters. The position peaked at $144M in Q2 2021. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • RTW Investments reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • RTW Investments sold 502,856 10x Genomics shares in Q4 2024, an estimated $11.4M.
  • RTW Investments first reported a position in 10x Genomics in Q3 2019 and held it in 21 quarters.
  • RTW Investments's 10x Genomics position peaked at $144M in Q2 2021.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on RTW Investments's 13F filing for Q4 2024, filed 14 Feb 2025.